Literature DB >> 2308600

Impaired function of macrophage Fc gamma receptors in end-stage renal disease.

P Ruiz1, F Gomez, A D Schreiber.   

Abstract

Infection is a frequent complication in patients undergoing hemodialysis for end-stage renal disease and is the primary cause of mortality among such patients. Macrophages are important in host defense against infection largely because their Fc gamma receptors recognize antibody-coated bacteria. We therefore studied macrophage Fc gamma-receptor function in vivo and in vitro in 56 patients with end-stage renal disease who were on hemodialysis and in 20 healthy volunteers. The clearance of IgG-coated (sensitized) autologous red cells was decreased in 53 patients. The inhibition of clearance in the 56 patients was 52 +/- 3 percent at 1 hour, 41 +/- 5 percent at 1 1/2 hours, and 29 +/- 5 percent at 2 hours (P less than 0.001). The clearance of unsensitized erythrocytes and heat-altered autologous erythrocytes was normal. The impairment of clearance was not correlated with age, sex, nutritional status, HLA haplotype, or the presence of circulating immune complexes. The recognition of these IgG-sensitized red cells in vitro by Fc gamma RI (an Fc gamma-receptor protein that binds monomeric IgG) on blood monocytes from the patients was also significantly decreased (P less than 0.001) but was partially improved by hemodialysis. Nine patients had severe infections during a two-year follow-up period. The clearance of IgG-coated cells in these patients (half-time, 12.9 +/- 1.7 hours) was significantly impaired, as compared with that in the 47 patients without severe infections (half-time, 4.4 +/- 1.8 hours; P less than 0.001). We conclude that macrophage Fc gamma-receptor function is impaired in patients with end-stage renal disease who are undergoing hemodialysis, and that this impairment probably contributes to the observed immunodepression and high prevalence of infection among such patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2308600     DOI: 10.1056/NEJM199003153221102

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  22 in total

1.  Augmentation of pulmonary host defense against Pseudomonas by FcgammaRIIA cDNA transfer to the respiratory epithelium.

Authors:  S Worgall; P Bezdicek; M K Kim; J G Park; R Singh; M Christofidou-Solomidou; A Prince; I Kovesdi; A D Schreiber; R G Crystal
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

2.  [Effect of zinc substitution on lymphocyte subsets and cellular immune function in hemodialysis patients].

Authors:  W Holtkamp; H P Brodersen; J Thiery; C Falkner; R Bolzius; D Larbig; H E Reis
Journal:  Klin Wochenschr       Date:  1991-06-18

3.  Potential role of soluble CD40 in the humoral immune response impairment of uraemic patients.

Authors:  Cécile Contin; Vincent Pitard; Yahsou Delmas; Nadège Pelletier; Thierry Defrance; Jean-François Moreau; Pierre Merville; Julie Déchanet-Merville
Journal:  Immunology       Date:  2003-09       Impact factor: 7.397

Review 4.  Viral hepatitis in elderly haemodialysis patients: current prevention and management strategies.

Authors:  Matthias Girndt
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

5.  Usefulness of preoperative estimated glomerular filtration rate to predict complications after curative gastrectomy in patients with clinical T2-4 gastric cancer.

Authors:  Yuri Tanaka; Mitsuro Kanda; Chie Tanaka; Daisuke Kobayashi; Akira Mizuno; Naoki Iwata; Masamichi Hayashi; Yukiko Niwa; Hideki Takami; Suguru Yamada; Tsutomu Fujii; Goro Nakayama; Hiroyuki Sugimoto; Michitaka Fujiwara; Yasuhiro Kodera
Journal:  Gastric Cancer       Date:  2016-10-12       Impact factor: 7.370

6.  Hepatitis B virus vaccine immune response and mortality in dialysis patients: a meta-analysis.

Authors:  Suwasin Udomkarnjananun; Kullaya Takkavatakarn; Kearkiat Praditpornsilpa; Claudia Nader; Somchai Eiam-Ong; Bertrand L Jaber; Paweena Susantitaphong
Journal:  J Nephrol       Date:  2019-11-07       Impact factor: 3.902

7.  Treatment with megestrol acetate improves human immunodeficiency virus-associated immune thrombocytopenia.

Authors:  Francisco Gomez; Pedro Ruiz; Rafaela Lopez; Consuelo Rivera
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

8.  Hepatitis C infection in children and adolescents on haemodialysis and after renal transplant.

Authors:  M Greco; K Cristiano; G Leozappa; M Rapicetta; G Rizzoni
Journal:  Pediatr Nephrol       Date:  1993-08       Impact factor: 3.714

9.  Dysregulated chemokine receptor expression and chemokine-mediated cell trafficking in pediatric patients with ESRD.

Authors:  Barbara Sherry; Wei Wei Dai; Martin L Lesser; Howard Trachtman
Journal:  Clin J Am Soc Nephrol       Date:  2008-01-30       Impact factor: 8.237

Review 10.  Diseases and drug-related interventions affecting host defence.

Authors:  S de Marie
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.